The differences lie in accessibility, cost, and customer service
National Institutes of Health
Clinical Studies 14.1 Overview of Clinical Studies The effectiveness of OZEMPIC tablets (1.5 mg, 4 mg and 9 mg strengths) [see Dosage and Administration (2.2)] and RYBELSUS (3 mg, 7, mg and 14 mg strengths) [see Dosage and Administration (2.3)] has been established as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus based on adequate and well-controlled studies of RYBELSUS in adult patients with type 2 diabetes mellitus [see Clinical Pharmacology (12.3)]
Some patients stay at lower doses if they experience good results and tolerate that level better, but 2.4 mg remains the therapeutic target
It remains unclear how long cessation of the medication would need to be for a meaningful effect on gastric emptying
Yes, and we often do, since coordinated care tends to serve patients best